“…The management of penile carcinoma has evolved in recent years, resulting in a shift in the treatment of the disease. 24 Options for the treatment of localized disease have expanded to organ-sparing therapy, and treatment of advanced disease has developed into a multidisciplinary, team-based approach using multimodal therapies. 24 Demographical, racial/ethnic, and socioeconomic disparities can influence the treatments offered for patients with penile cancer in different populations (Table 2).…”